In what is being hailed as the biggest breakthrough since the 1960s in treatment for latent tuberculosis — noninfectious TB without symptoms — researchers said Monday that weekly doses of a cocktail ...

Treating children and adults who have latent tuberculosis infection (LTBI) with 4 months of rifampin (Rifadin, Sanofi-Aventis) had similar rates of safety and efficacy but a better adherence rate than ...

DENVER -- In patients with tuberculosis (TB), a novel fixed-dose combination of alpibectir-ethionamide had similar levels of bactericidal activity as isoniazid, with no serious adverse events and good ...

Treatment of latent tuberculosis has never been a simple affair. Nine months of a drug known as isoniazid, taken daily, is the standard of care and can help clear the infection. But it also causes ...

Montreal, Aug. 1, 2018 - Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) revealed that a ...

A study examining pharmacokinetic interactions between the first-line HIV drug dolutegravir and a once-weekly tuberculosis regimen was terminated early after NIH researchers found that the combined ...

A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, ...

A Hospital consultant was apologetic to the relatives of a woman who died from a toxic side-effect of a drug prescribed to ...

Study results help clarify how to safely prevent tuberculosis (TB) in women living with HIV who are pregnant or have recently given birth, are taking antiretroviral therapy, and live where TB is ...